Lupus News

Comparing gut bacteria from lupus patients with bacteria from their healthy peers, scientists learned those with lupus had about five times more of the bacteria known as Ruminococcus gnavus.

But stress may trigger the reverse, researchers report

Studies find race, ethnicity, gender and even geography make a difference for this autoimmune disease

Certain cells seem to malfunction and create inflammation instead of fighting the disease, research say

As early as 12 weeks, checks can signal danger of complications for both mother and baby, study contends

But blacks, Hispanics face greater odds of complications than whites, though reasons why are unclear

Asians, Hispanics most likely to survive the autoimmune disease

Headache, seizures often lead doctors down the wrong path

Drugs that suppress the immune system make it harder to fight infection, study says

High blood pressure and steroid medication may worsen lupus, a chronic inflammatory disease that can affect the joints, skin, kidneys, lungs, nervous system and other organs.

Drugs can reduce symptoms of autoimmune disease, ward off serious complications

Study followed nearly 15,000 patients for 6 years

A drug related to thalidomide may be more potent and less toxic than thalidomide, which is often used to treat lupus skin conditions.

Aimee Copeland, the young Georgia woman battling infection with flesh-eating bacteria, reportedly has lupus. In this expert Q&A, rheumatologist Chaim Putterman discusses lupus and the risk of necrotizing fasciitis.

When lupus attacks the kidneys, the damage can be life-threatening. Now, updated guidelines from the American College of Rheumatology are aimed at identifying kidney involvement in lupus early and treating it aggressively to stop this damage in its tracks.

In the first study of its kind, high doses of vitamin D were safe and appeared to temper some of the destructive immune system responses believed to cause lupus.

The FDA has approved Benlysta, the first new drug for lupus in 50 years. What is it? Which patients will benefit? Which won't? Is it safe? WebMD's FAQ.

The FDA has approved Benlysta, the first new lupus drug since 1955. Benlysta reduces lupus activity; it's hoped the drug will help patients reduce their need for steroids.

Researchers think they may have discovered the mechanism that drives the body’s attack on its own cells and tissues in the autoimmune disease lupus.

At the end of a day of often emotional testimony, an FDA advisory panel overwhelmingly voted to recommend the approval of a new drug for the treatment of systemic lupus.

People with lupus given the first in a new class of experimental drugs that targets the disease process did better than those given standard treatment, according to one-year results of a large clinical trial.

The routine use of cholesterol-lowering statin drugs in children and adolescents with systemic lupus is not warranted, a new study suggests.

People with systemic lupus are 15% times more likely to develop cancer compared with the general population, suggest findings of a study involving nearly 13,500 people with systemic lupus.

Women who spray their homes and gardens with insecticides may be placing themselves at risk for rheumatoid arthritis and lupus, a study shows.

The first in a new class of experimental drugs that targets the disease process involved in lupus beat out standard treatment in a large clinical trial, researchers say.